07.12.2023 - CHICAGO, IL / ACCESSWIRE / December 7, 2023 / Cosmos Health Inc. ( Cosmos Health or the Company ) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and . Seite 1
Japanese drugmaker Eisai and US-based Biogen have received FDA approval for Leqembi, making it the first approved treatment available that can slow the progression of Alzheimer’s in patients.